EP4346796A1 — Delayed release compositions of dimethyl fumarate
Assigned to ZIM Laboratories Ltd · Expires 2024-04-10 · 2y expired
What this patent protects
The present invention relates to delayed release pharmaceutical compositions comprising dimethyl fumarate in the treatment of multiple sclerosis. The delayed release composition of dimethyl fumarate is having particle size (D90) of dimethyl fumarate in the composition is less tha…
USPTO Abstract
The present invention relates to delayed release pharmaceutical compositions comprising dimethyl fumarate in the treatment of multiple sclerosis. The delayed release composition of dimethyl fumarate is having particle size (D90) of dimethyl fumarate in the composition is less than 50µm and composition is manufactured by extrusion- spheronization or layering method.
Drugs covered by this patent
- Tecfidera (DIMETHYL FUMARATE) · Biogen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.